Nurse Workforce Projections

Nurse Workforce Projections

According to bhw.hrsa.gov, the forecasts are based on historical data, including some from 2021. The COVID-19 pandemic had a significant influence on the nursing workforce, which may not be fully recorded in current statistics. Data for this analysis are presented at 5-year intervals (2026, 2031, and 2036).

The nursing shortage of registered nurses (RNs) across the US is projected to reach 9% by 2036, with a 10% shortage in 2026 and 2031

Non-metro areas are expected to have a higher nursing shortage than metro areas in each of the three interval years

The demand for licensed practical and vocational nurses (LPNs) is projected to grow faster than supply, resulting in a shortage of 99,070 LPN FTEs in 2036

The projected supply of LPNs is sufficient to meet 88% of the demand, compared to 93% in 2026. At the national level, the supply of nurse practitioners (NPs) is projected to exceed demand, but distribution remains the most important issue

LPN supply adequacy varies across states, with a 75% shortage in Maine and a 65% oversupply in Oklahoma in 2036

Demand and supply estimates and predictions are based on full-time equivalents (FTEs), which are defined as 40 hours per week.FTE figures maydiffer from estimated health workforce headcounts. Percent adequacy is computed by dividing predicted supply by projected demand.

Source : hrsa.gov

Demand and supply estimates and predictions are based on full-time equivalents (FTEs), which are defined as 40 hours per week.FTE figures maydiffer from estimated health workforce headcounts. Percent adequacy is computed by dividing predicted supply by projected demand.

Source : hrsa.gov

Demand and supply estimates and predictions are based on full-time equivalents (FTEs), which are defined as 40 hours per week.FTE figures maydiffer from estimated health workforce headcounts. Percent adequacy is computed by dividing predicted supply by projected demand.

Source : hrsa.gov

Related post

FDA Approves First-of-its-Kind Treatment for Rare Lung Disease in Over a Decade

FDA Approves First-of-its-Kind Treatment for Rare Lung Disease in…

Highlights: Jascayd tablets represents the first-of-its-kind therapy for idiopathic pulmonary fibrosis (IPF) in more than a decade Patients are able to…
Microsoft’s Rural Health Resilience Program Making Waves

Microsoft’s Rural Health Resilience Program Making Waves

Highlights: The losses incurred in denied claims amounts to USD 3,30,000 in the US annually Claim denials navigator is a free-to-use…
AstraZeneca’s DatroWay Delivers Breakthrough in Advanced Breast Cancer Survival

AstraZeneca’s DatroWay Delivers Breakthrough in Advanced Breast Cancer Survival

Highlights: DatroWay, a new innovation by AstraZeneca, boosts survival odds among advanced breast cancer patients DatroWay utilises ADC that delivers high-precision…